Can mac-2 binding protein glycosylation isomer serve as a biomarker for predicting pulmonary arterial pressure and pulmonary hypertension in systemic sclerosis?
Turkish Journal of Medical Sciences · 17.04.2025 · 55 (2) · 404-412
DOI: 10.55730/1300-0144.5984 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turkish Journal of Medical Sciences, online erschienen am 17.04.2025. Verfasst von Rıdvan Mercan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Faculty of Medicine, Tekirdağ Namık Kemal University, Tekirdağ, Turkiye. Hauptthemen laut MEDLINE: Scleroderma, Systemic, Hypertension, Pulmonary, Membrane Glycoproteins, Antigens, Neoplasm. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/aim: This study aimed to explore the role of Mac-2 binding protein glycosylation isomer (M2BPGi) serum levels as a biomarker that could contribute to understanding organ involvement and the overall disease process in systemic sclerosis (SSc). Materials and methods: The cross-sectional study examined 108 patients with SSc. Seventy-two people were included in the control group. Demographic and clinical characteristics of the patients, laboratory and radiological findings, pulmonary function tests and echocardiography results, and presence of pulmonary hypertension (PHT) based on echocardiographic evaluation were recorded. Venous blood samples of 5 mL were collected from individuals. Human M2BPGi levels in the samples were measured using a specific kit.
Results
There was no significant difference between the M2BPGi levels in the patient (median = 4749.69 pg/mL, mean = 5351.75 ± 2483.97) and the control group (median = 4638.07, mean = 4611.86 ± 1333.15) (p = 0.071). Considering pulmonary arterial pressure (PAP) status, the average M2BPGi level in the normal PAP group was 5898.15 ± 2555.61 pg/mL, while it was 4258.96 ± 1973.08 pg/mL in the increased PAP group. The difference between these groups was statistically significant (p: 0.021). Examining PHT status, the average M2BPGi level was 5942.01 ± 2579.14 pg/mL in the group without PHT, decreasing to 4264.44 ± 1917.63 pg/mL in the group with PHT. There is a significant relationship regarding PHT (p: 0.016).
Conclusion
This study explores the relationship between M2BPGi and systemic involvements in SSc. It demonstrates a significant relationship between M2BPGi and PAP and PHT, suggesting that M2BPGi might serve as a noninvasive biomarker for predicting both PAP and PHT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology, Faculty of Medicine, Tekirdağ Namık Kemal University, Tekirdağ, Turkiye.
- Department of Internal Medicine, Faculty of Medicine, Tekirdağ Namık Kemal University, Tekirdağ, Turkiye.
- Department of Biochemistry, Faculty of Medicine, Tekirdağ Namık Kemal University, Tekirdağ, Turkiye.
ORCID-Profile: Rıdvan Mercan, Dilara Bulut Gökten, Sonat Pınar Kara, Neslihan Melik Üzüm, Savaş Güzel
Zitieren
APA
Mercan, R., Gökten, D. B., Kara, S. P., Üzüm, N. M., & Güzel, S. (2025). Can mac-2 binding protein glycosylation isomer serve as a biomarker for predicting pulmonary arterial pressure and pulmonary hypertension in systemic sclerosis?. Turkish Journal of Medical Sciences, 55(2), 404-412. https://doi.org/10.55730/1300-0144.5984
Vancouver
Mercan R, Gökten DB, Kara SP, Üzüm NM, Güzel S. Can mac-2 binding protein glycosylation isomer serve as a biomarker for predicting pulmonary arterial pressure and pulmonary hypertension in systemic sclerosis?. Turkish Journal of Medical Sciences. 2025;55(2):404-412. doi:10.55730/1300-0144.5984
BibTeX
@article{Mercan2025,
author = {Mercan, Rıdvan and Gökten, Dilara Bulut and Kara, Sonat Pınar and Üzüm, Neslihan Melik and Güzel, Savaş},
title = {Can mac-2 binding protein glycosylation isomer serve as a biomarker for predicting pulmonary arterial pressure and pulmonary hypertension in systemic sclerosis?},
journal = {Turkish Journal of Medical Sciences},
year = {2025},
volume = {55},
number = {2},
pages = {404--412},
doi = {10.55730/1300-0144.5984}
}
EUVIMED